Nalaganje...
Inhibition of Sodium-GlucoseCotransporter 2 with Dapagliflozin in Han: SPRD Rats with Polycystic Kidney Disease
Background/Aims: Dapagliflozin (DAPA) is a selective inhibitor of the sodium-glucose cotransporter 2 (SGLT2) which induces glucosuria and osmotic diuresis. The therapeutic effect of DAPA in progressing stages of polycystic kidney disease (PKD) has not been studied. Methods: We examined the effect of...
Shranjeno v:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Karger Publishers
2015-12-01
|
| Serija: | Kidney & Blood Pressure Research |
| Teme: | |
| Online dostop: | http://www.karger.com/Article/FullText/368540 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|